{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:32:42Z","timestamp":1790947962402,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:00:00Z","timestamp":1737158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:00:00Z","timestamp":1737158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271847"],"award-info":[{"award-number":["82271847"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s10067-024-07273-z","type":"journal-article","created":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T09:24:23Z","timestamp":1737192263000},"page":"1225-1236","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinical and laboratory characteristics of Sj\u00f6gren\u2019s syndrome-associated autoimmune liver disease: a real-world, 10-year retrospective study"],"prefix":"10.1007","volume":"44","author":[{"given":"Peixuan","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaozhe","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jixin","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2017-1125","authenticated-orcid":false,"given":"Lingli","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,18]]},"reference":[{"key":"7273_CR1","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.3748\/wjg.v28.i23.2527","volume":"28","author":"C-R Wang","year":"2022","unstructured":"Wang C-R, Tsai H-W (2022) Autoimmune liver diseases in systemic rheumatic diseases. World J Gastroenterol 28:2527\u20132545","journal-title":"World J Gastroenterol"},{"key":"7273_CR2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.rdc.2017.09.008","volume":"44","author":"C Selmi","year":"2018","unstructured":"Selmi C, Generali E, Gershwin ME (2018) Rheumatic manifestations in autoimmune liver disease. Rheumatic Disease Clinics of North America 44:65\u201387","journal-title":"Rheumatic Disease Clinics of North America"},{"key":"7273_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1471-230X-2-21","volume":"2","author":"MJ Kaplan","year":"2002","unstructured":"Kaplan MJ, Ike RW (2002) The liver is a common non-exocrine target in primary Sj\u00f6gren\u2019s syndrome: a retrospective review. BMC Gastroenterol 2:21","journal-title":"BMC Gastroenterol"},{"key":"7273_CR4","first-page":"e2376231","volume":"2017","author":"L Guo","year":"2017","unstructured":"Guo L, Zhou L, Zhang N, Deng B, Wang B (2017) Extrahepatic autoimmune diseases in patients with autoimmune liver diseases: a phenomenon neglected by gastroenterologists. Gastroenterology Research and Practice Hindawi 2017:e2376231","journal-title":"Gastroenterology Research and Practice Hindawi"},{"key":"7273_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejim.2018.10.014","volume":"59","author":"A Floreani","year":"2019","unstructured":"Floreani A, De Martin S, Secchi MF, Cazzagon N (2019) Extrahepatic autoimmunity in autoimmune liver disease. Eur J Intern Med 59:1\u20137","journal-title":"Eur J Intern Med"},{"key":"7273_CR6","doi-asserted-by":"publisher","first-page":"100746","DOI":"10.1016\/j.aohep.2022.100746","volume":"27","author":"X Deng","year":"2022","unstructured":"Deng X, Li J, Hou S, Ci B, Liu B, Xu K (2022) Prevalence and impact of sj\u00f6gren\u2019s syndrome in primary biliary cholangitis: a systematic review and meta-analysis. Ann Hepatol 27:100746","journal-title":"Ann Hepatol"},{"key":"7273_CR7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jaut.2012.05.008","volume":"39","author":"MJ Amador-Patarroyo","year":"2012","unstructured":"Amador-Patarroyo MJ, Arbelaez JG, Mantilla RD et al (2012) Sj\u00f6gren\u2019s syndrome at the crossroad of polyautoimmunity. J Autoimmun 39:199\u2013205","journal-title":"J Autoimmun"},{"key":"7273_CR8","first-page":"582","volume":"3","author":"JK Karp","year":"2010","unstructured":"Karp JK, Akpek EK, Anders RA (2010) Autoimmune hepatitis in patients with primary sj\u00f6gren\u2019s syndrome: a series of two-hundred and two patients. Int J Clin Exp Path 3:582\u2013586","journal-title":"Int J Clin Exp Path"},{"key":"7273_CR9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41575-019-0226-7","volume":"17","author":"AF Gulamhusein","year":"2020","unstructured":"Gulamhusein AF, Hirschfield GM (2020) Primary biliary cholangitis: pathogenesis and therapeutic opportunities. Nat Rev Gastroenterol Hepatol 17:93\u2013110","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"7273_CR10","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/hep.31065","volume":"72","author":"CL Mack","year":"2020","unstructured":"Mack CL, Adams D, Assis DN et al (2020) Diagnosis and management of autoimmune hepatitis in adults and children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases. Hepatology 72:671\u2013722","journal-title":"Hepatology"},{"key":"7273_CR11","doi-asserted-by":"publisher","first-page":"5645","DOI":"10.1097\/MS9.0000000000001143","volume":"85","author":"S Acharya","year":"2023","unstructured":"Acharya S, Shrestha S, Poddar E et al (2023) Antimitochondrial antibody-negative primary biliary cirrhosis with secondary Sjogren syndrome: a case report. Ann Med Surg (Lond) 85:5645\u20135648","journal-title":"Ann Med Surg (Lond)"},{"key":"7273_CR12","first-page":"63","volume":"5","author":"MS Asghar","year":"2020","unstructured":"Asghar MS, Tauseef A, Khan N, Zafar M, Rasheed U, Hassan M (2020) Sj\u00f6gren\u2019s syndrome complicated with type 2 autoimmune hepatitis: a case report-based review of the literature. EMJ European Medical Journal 5:63\u201369","journal-title":"EMJ European Medical Journal"},{"key":"7273_CR13","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/acr.21591","volume":"64","author":"SC Shiboski","year":"2012","unstructured":"Shiboski SC, Shiboski CH, Criswell LA et al (2012) American College of Rheumatology classification criteria for Sj\u00f6gren\u2019s syndrome: a data-driven, expert consensus approach in the Sj\u00f6gren\u2019s International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken) 64:475\u2013487","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"7273_CR14","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jhep.2020.07.032","volume":"74","author":"J Galaski","year":"2021","unstructured":"Galaski J, Weiler-Normann C, Schakat M et al (2021) Update of the simplified criteria for autoimmune hepatitis: evaluation of the methodology for immunoserological testing. J Hepatol 74:312\u2013320","journal-title":"J Hepatol"},{"key":"7273_CR15","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","volume":"67","author":"GM Hirschfield","year":"2017","unstructured":"Hirschfield GM, Beuers U, Corpechot C et al (2017) EASL clinical practice guidelines: the diagnosis and management of patients with primary biliary cholangitis. J Hepatol 67:145\u2013172","journal-title":"J Hepatol"},{"key":"7273_CR16","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/hep.510280203","volume":"28","author":"O Chazouill\u00e8res","year":"1998","unstructured":"Chazouill\u00e8res O, Wendum D, Serfaty L, Montembault S, Rosmorduc O, Poupon R (1998) Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy: primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy. Hepatology 28:296\u2013301","journal-title":"Hepatology"},{"key":"7273_CR17","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1111\/liv.15155","volume":"42","author":"T Katsumi","year":"2022","unstructured":"Katsumi T, Ueno Y (2022) Epidemiology and surveillance of autoimmune hepatitis in Asia. Liver Int 42:2015\u20132022","journal-title":"Liver Int"},{"key":"7273_CR18","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s12016-014-8432-0","volume":"48","author":"Q Miao","year":"2015","unstructured":"Miao Q, Bian Z, Tang R et al (2015) Emperipolesis mediated by CD8 T cells is a characteristic histopathologic feature of autoimmune hepatitis. Clin Rev Allergy Immunol 48:226\u2013235","journal-title":"Clin Rev Allergy Immunol"},{"key":"7273_CR19","doi-asserted-by":"publisher","first-page":"103591","DOI":"10.1016\/j.autrev.2024.103591","volume":"23","author":"MS Longhi","year":"2024","unstructured":"Longhi MS, Zhang L, Mieli-Vergani G, Vergani D (2024) B and T cells: (still) the dominant orchestrators in autoimmune hepatitis. Autoimmun Rev 23:103591","journal-title":"Autoimmun Rev"},{"key":"7273_CR20","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jaut.2011.11.005","volume":"39","author":"C Selmi","year":"2012","unstructured":"Selmi C, Meroni PL, Gershwin ME (2012) Primary biliary cirrhosis and Sj\u00f6gren\u2019s syndrome: autoimmune epithelitis. J Autoimmun 39:34\u201342","journal-title":"J Autoimmun"},{"key":"7273_CR21","doi-asserted-by":"publisher","first-page":"106386","DOI":"10.1016\/j.intimp.2020.106386","volume":"83","author":"Y Li","year":"2020","unstructured":"Li Y, Xi Y, Tao G et al (2020) Sirtuin 1 activation alleviates primary biliary cholangitis via the blocking of the NF-\u03baB signaling pathway. Int Immunopharmacol 83:106386","journal-title":"Int Immunopharmacol"},{"key":"7273_CR22","doi-asserted-by":"publisher","first-page":"19772","DOI":"10.1038\/s41598-022-21816-x","volume":"12","author":"G Xu","year":"2022","unstructured":"Xu G, Gong Y, Lu F et al (2022) Endothelin receptor B enhances liver injury and pro-inflammatory responses by increasing G-protein-coupled receptor kinase-2 expression in primary biliary cholangitis. Sci Rep 12:19772","journal-title":"Sci Rep"},{"key":"7273_CR23","doi-asserted-by":"publisher","first-page":"102904","DOI":"10.1016\/j.jaut.2022.102904","volume":"133","author":"X Li","year":"2022","unstructured":"Li X, Zhang Y, Wang J et al (2022) zVAD alleviates experimental autoimmune hepatitis in mice by increasing the sensitivity of macrophage to TNFR1-dependent necroptosis. J Autoimmun 133:102904","journal-title":"J Autoimmun"},{"key":"7273_CR24","doi-asserted-by":"publisher","first-page":"631","DOI":"10.2147\/DDDT.S99420","volume":"10","author":"S Li","year":"2016","unstructured":"Li S, Xia Y, Chen K et al (2016) Epigallocatechin-3-gallate attenuates apoptosis and autophagy in concanavalin A-induced hepatitis by inhibiting BNIP3. Drug Des Devel Ther 10:631\u2013647","journal-title":"Drug Des Devel Ther"},{"key":"7273_CR25","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1080\/08923973.2022.2093741","volume":"44","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Chen J, Yao Z, Gu X (2022) Gastrodin ameliorates Concanavalin A-induced acute hepatitis via the IL6\/JAK2\/STAT3 pathway. Immunopharmacol Immunotoxicol 44:925\u2013934","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"7273_CR26","first-page":"392","volume":"9","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, Xu B-H, Rodgers B, Pyrsopoulos N (2021) Characteristics and inpatient outcomes of primary biliary cholangitis and autoimmune hepatitis overlap syndrome. J Clin Transl Hepatol 9:392\u2013398","journal-title":"J Clin Transl Hepatol"},{"key":"7273_CR27","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1111\/j.1572-0241.2007.01136.x","volume":"102","author":"MG Silveira","year":"2007","unstructured":"Silveira MG, Talwalkar JA, Angulo P, Lindor KD (2007) Overlap of autoimmune hepatitis and primary biliary cirrhosis: long-term outcomes. Am J Gastroenterol 102:1244\u20131250","journal-title":"Am J Gastroenterol"},{"key":"7273_CR28","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.cld.2014.09.005","volume":"19","author":"C Bunchorntavakul","year":"2015","unstructured":"Bunchorntavakul C, Reddy KR (2015) Diagnosis and management of overlap syndromes. Clin Liver Dis 19:81\u201397","journal-title":"Clin Liver Dis"},{"key":"7273_CR29","first-page":"1884","volume":"29","author":"S Tsunawaki","year":"2002","unstructured":"Tsunawaki S, Nakamura S, Ohyama Y et al (2002) Possible function of salivary gland epithelial cells as nonprofessional antigen-presenting cells in the development of Sj\u00f6gren\u2019s syndrome. The Journal of Rheumatology The Journal of Rheumatology 29:1884\u20131896","journal-title":"The Journal of Rheumatology The Journal of Rheumatology"},{"key":"7273_CR30","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jaut.2006.11.004","volume":"27","author":"J Allina","year":"2006","unstructured":"Allina J, Hu B, Sullivan DM et al (2006) T cell targeting and phagocytosis of apoptotic biliary epithelial cells in primary biliary cirrhosis. J Autoimmun 27:232\u2013241","journal-title":"J Autoimmun"},{"key":"7273_CR31","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s12016-015-8471-1","volume":"48","author":"Y Sun","year":"2015","unstructured":"Sun Y, Zhang W, Li B, Zou Z, Selmi C, Gershwin ME (2015) The coexistence of Sj\u00f6gren\u2019s syndrome and primary biliary cirrhosis: a comprehensive review. Clinic Rev Allerg Immunol 48:301\u2013315","journal-title":"Clinic Rev Allerg Immunol"},{"key":"7273_CR32","unstructured":"Bhumi SA, Wu GY (2023) Seronegative autoimmune hepatitis. Journal of Clinical and Translational Hepatology Xia & He Publishing Inc. 11:459\u2013465"},{"key":"7273_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2022.103143","volume":"21","author":"MV Lenti","year":"2022","unstructured":"Lenti MV, Rossi CM, Melazzini F et al (2022) Seronegative autoimmune diseases: a challenging diagnosis. Autoimmun Rev 21:103143","journal-title":"Autoimmun Rev"},{"key":"7273_CR34","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jaut.2018.10.004","volume":"95","author":"B Terziroli Beretta-Piccoli","year":"2018","unstructured":"Terziroli Beretta-Piccoli B, Mieli-Vergani G, Vergani D (2018) The clinical usage and definition of autoantibodies in immune-mediated liver disease: a comprehensive overview. J Autoimmun 95:144\u2013158","journal-title":"J Autoimmun"},{"key":"7273_CR35","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/S0168-8278(99)80096-8","volume":"30","author":"AJ Czaja","year":"1999","unstructured":"Czaja AJ (1999) Behavior and significance of autoantibodies in type 1 autoimmune hepatitis. J Hepatol 30:394\u2013401","journal-title":"J Hepatol"},{"key":"7273_CR36","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jhep.2010.01.037","volume":"53","author":"MMH Lamers","year":"2010","unstructured":"Lamers MMH, van Oijen MGH, Pronk M, Drenth JPH (2010) Treatment options for autoimmune hepatitis: a systematic review of randomized controlled trials. Journal of Hepatology Elsevier 53:191\u2013198","journal-title":"Journal of Hepatology Elsevier"},{"key":"7273_CR37","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.jhep.2023.11.032","volume":"80","author":"RJALM Snijders","year":"2024","unstructured":"Snijders RJALM, Stoelinga AEC, Gevers TJG et al (2024) An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis. J Hepatol 80:576\u2013585","journal-title":"J Hepatol"},{"key":"7273_CR38","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1111\/j.1600-6143.2009.03006.x","volume":"10","author":"AJ Montano-Loza","year":"2010","unstructured":"Montano-Loza AJ, Wasilenko S, Bintner J, Mason AL (2010) Cyclosporine A protects against primary biliary cirrhosis recurrence after liver transplantation. Am J Transplant 10:852\u2013858","journal-title":"Am J Transplant"},{"key":"7273_CR39","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/liv.14378","volume":"40","author":"B Engel","year":"2020","unstructured":"Engel B, Taubert R, Jaeckel E, Manns MP (2020) The future of autoimmune liver diseases \u2013 understanding pathogenesis and improving morbidity and mortality. Liver Int 40:149\u2013153","journal-title":"Liver Int"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07273-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-024-07273-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07273-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T08:22:19Z","timestamp":1740558139000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-024-07273-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,18]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["7273"],"URL":"https:\/\/doi.org\/10.1007\/s10067-024-07273-z","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,18]]},"assertion":[{"value":"3 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted according to the ethical principles of the Declaration of Helsinki and approved by the Ethics Committee of Tongji Hospital (Wuhan, China) (TJ-IRB20230427).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"Patients and\/or the public were not involved in the design, conduct, reporting, or dissemination plans of this research.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient and public involvement"}}]}}